Agilent Technologies
APhase 2Agilent Technologies operates as a diversified life sciences and diagnostics company serving pharmaceutical, biotechnology, clinical, environmental, and food testing markets worldwide. Founded in 1999 as a spin-off from Hewlett-Packard, the company has grown through strategic acquisitions and innovation to become a market leader in analytical instrumentation. With over 18,000 employees globally, Agilent generates approximately $7 billion in annual revenue and maintains a strong position in high-growth markets including personalized medicine, cell and gene therapy, and food safety.
A · Stock Price
Historical price data
AI Company Overview
Agilent Technologies operates as a diversified life sciences and diagnostics company serving pharmaceutical, biotechnology, clinical, environmental, and food testing markets worldwide. Founded in 1999 as a spin-off from Hewlett-Packard, the company has grown through strategic acquisitions and innovation to become a market leader in analytical instrumentation. With over 18,000 employees globally, Agilent generates approximately $7 billion in annual revenue and maintains a strong position in high-growth markets including personalized medicine, cell and gene therapy, and food safety.
Technology Platform
Comprehensive analytical instrumentation platform including LC-MS, GC-MS, genomics tools, cell analysis systems, and laboratory automation solutions for life sciences research, diagnostics, and applied markets.
Pipeline Snapshot
11 drug in pipeline
| Drug | Indication | Stage |
|---|---|---|
| NK Cell enriched-DLI only + NK-DLI + DUK-CPG-001 | Myeloid Malignancies | Phase 2 |
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competes primarily with Thermo Fisher Scientific, Waters Corporation, and Danaher in analytical instrumentation. Differentiates through comprehensive portfolio integration, strong service capabilities, and deep customer relationships across diverse end markets.
Company Info
Trading
Contact
Therapeutic Areas
Partners
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile